Summary: The Centers for Medicare & Medicaid Services modified its coverage policy for electrical continence aids, effective May 15, 2026. Here's what billing teams need to know before that date.
CMS electrical continence aid coverage policy changes affect durable medical equipment suppliers and urology/urogynecology practices billing for these devices. The policy does not list specific HCPCS or CPT codes in the available documentation — we'll note exactly where that gap lands for your billing team below. If you bill Medicare for any continence device or neurostimulation-adjacent DME, this modification deserves your attention before May 15, 2026.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Electrical Continence Aid |
| Policy Code | N/A |
| Change Type | Modified |
| Effective Date | May 15, 2026 |
| Impact Level | Medium-High |
| Specialties Affected | Urology, Urogynecology, DME suppliers, Physical Medicine & Rehabilitation |
| Key Action | Review your charge capture and prior authorization workflows for electrical continence devices before May 15, 2026 |
CMS Electrical Continence Aid Coverage Criteria and Medical Necessity Requirements 2026
The CMS electrical continence aid coverage policy governs Medicare reimbursement for devices that use electrical stimulation to treat urinary or fecal incontinence. These are not surgical implants like sacral neuromodulators — they're external or minimally invasive devices that deliver electrical stimulation to pelvic floor muscles or peripheral nerves to restore continence.
Medical necessity is always the central issue with these devices. CMS has historically required documented conservative treatment failure before it covers electrical stimulation for incontinence. That typically means a trial of pelvic floor muscle training (PFMT), behavioral therapies, and pharmacological management — with documented outcomes showing inadequate response.
The modified coverage policy may tighten or clarify those medical necessity criteria. Because the full policy text is not yet available through PayerPolicy's source document at the time of publication, we cannot quote specific language. What we can tell you: when CMS modifies a coverage policy like this one, the change typically falls into one of three buckets — updated medical necessity criteria, revised documentation requirements, or a shift in how certain device categories are classified.
Watch for any language that redefines what qualifies as a covered electrical continence aid versus what gets pushed into experimental or investigational status. That line has moved before, and it will move again. If your practice or your DME supplier is billing for any device in this category, you need the full policy text in hand before May 15, 2026.
A note on prior authorization: CMS does not administer prior authorization the same way commercial payers do for most DME categories, but Medicare Administrative Contractors can issue prior authorization requirements for certain durable medical equipment through the Prior Authorization Program for certain DME items. Whether this policy modification triggers any new prior authorization requirements is something your MAC will determine. Check with your regional MAC and your compliance officer before the effective date.
CMS Electrical Continence Aid Exclusions and Non-Covered Indications
CMS has consistently treated certain electrical stimulation applications as non-covered under Medicare. The real issue here is the boundary between covered electrical continence aids and devices that CMS classifies as experimental or investigational — that boundary is where claim denial risk lives.
Devices without sufficient clinical evidence of effectiveness for a specific incontinence indication have historically landed in the "not covered" column. This includes some home-use transcutaneous electrical nerve stimulation (TENS) devices marketed for incontinence when the clinical evidence doesn't meet CMS's threshold for medical necessity.
Coverage policy exclusions also typically apply when the device is being used for an indication outside the approved scope — for example, using a device indicated for urinary incontinence to treat fecal incontinence, or billing for a device in a setting that doesn't match the coverage criteria.
Because the specific exclusion language from this modified policy is not available in the current documentation, your compliance officer should pull the full LCD or NCD text directly from CMS.gov or your MAC's website as soon as it publishes. Do not wait for a claim denial to find out where the new lines are drawn.
Coverage Indications at a Glance
The policy data provided for this modification does not include specific indication-level criteria. The table below reflects what CMS coverage policy has historically addressed for electrical continence aids. Verify each row against the published policy before May 15, 2026 — do not treat this as final coverage guidance.
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Urinary incontinence — electrical stimulation after failed conservative therapy | Historically Covered (verify against modified policy) | Not listed in available policy data | Medical necessity documentation required |
| Fecal incontinence — electrical stimulation | Coverage status unclear under modified policy | Not listed in available policy data | High claim denial risk — verify before billing |
| Home-use electrical stimulation devices for incontinence | Historically limited / non-covered in some LCDs | Not listed in available policy data | MAC-level LCD variation applies |
| Experimental / investigational electrical continence devices | Not Covered | Not listed in available policy data | No reimbursement without sufficient clinical evidence |
CMS Electrical Continence Aid Billing Guidelines and Action Items 2026
Here's what your billing team and DME suppliers need to do right now.
| # | Action Item |
|---|---|
| 1 | Pull the full policy text from CMS.gov or your MAC's LCD database before April 15, 2026. Give yourself a full month before the May 15, 2026 effective date to review the changes. Local coverage determinations from your MAC may contain more specific billing guidelines than the national policy — check both. |
| 2 | Audit your current charge capture for any electrical continence device codes. The policy does not list specific HCPCS or CPT codes in the available documentation, but electrical continence aid billing typically runs through the E-code HCPCS range. Pull every claim your team has submitted in the last 12 months for devices in this category. That's your exposure map. |
| 3 | Review your medical necessity documentation protocols. When CMS modifies a coverage policy like this one, documentation requirements often tighten. Make sure your clinical team captures failed conservative treatment, diagnosis specificity, and functional limitations in a way that maps directly to the updated criteria — not just general clinical notes. |
| 4 | Confirm prior authorization requirements with your MAC. As noted above, your regional Medicare Administrative Contractor controls whether prior authorization applies to specific DME items under the Prior Authorization Program. Call or check your MAC's website. Don't assume the old workflow still applies after May 15, 2026. |
| 5 | Update your ABN workflow if coverage criteria narrow. If the modified coverage policy excludes indications that were previously covered, patients may still want the device. Your Advanced Beneficiary Notice of Noncoverage (ABN) process needs to reflect the updated coverage policy before claims go out. A claim denial after the fact is the worst way to discover your ABN workflow was out of date. |
| 6 | Talk to your compliance officer about the boundary between covered and non-covered devices. If your practice or your DME supplier bills for multiple device types in the electrical continence category, some may fall on the covered side of the new policy and some may not. That's a classification question with real reimbursement consequences. Don't make that call alone — loop in your compliance officer before the effective date. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Electrical Continence Aid Under CMS Policy
A Direct Note on Code Availability
The policy data provided for this CMS electrical continence aid modification does not include specific CPT, HCPCS, or ICD-10 codes. We do not fabricate or guess codes here — that's how billing errors and claim denials happen.
This is the single biggest gap in the available policy documentation right now. Electrical continence aid billing typically involves HCPCS codes in the E-code (DME) range, but the exact codes that fall under this modified coverage policy must come from the official CMS publication or your MAC's LCD.
What to do: Go to the CMS Coverage Database at cms.gov/medicare-coverage-database and search for "electrical continence" under National Coverage Determinations and Local Coverage Determinations. Your MAC's website will have the most granular, billable code list tied to this specific policy.
Until those codes are confirmed from the official source, do not update your charge capture based on assumptions. One wrong HCPCS code on a DME claim creates a claim denial that takes weeks to resolve — and if the device was delivered before the denial, you're in a worse position.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.